Literature DB >> 25163432

Model drug as pore former for controlled release of water-soluble metoprolol succinate from ethylcellulose-coated pellets without lag phase: opportunities and challenges.

Yuli Wang1, Jingjing Dai, Xinyi Chang, Meiyan Yang, Ruifang Shen, Li Shan, Yong Qian, Chunsheng Gao.   

Abstract

The objective of the present study was to evaluate the feasibility of using model drug metoprolol succinate (MS) as a pore former to modify the initial lag phase (i.e., a slow or non-release phase in the first 1-2 h) associated with the drug release from coated pellets. MS-layered cores with high drug-layering efficiency (97% w/w) were first prepared by spraying a highly concentrated drug aqueous solution (60% w/w, 70°C) on non-pareils without using other binders. The presence of MS in ethylcellulose (EC) coating solution significantly improved the coating process by reducing pellets sticking, which often occurs during organic coating. There may be a maximum physical compatibility of MS with EC, and the physical state of the drug in the functional coating layer of EC/MS (80:20) was simultaneously crystalline and non-crystalline (amorphous or solid molecule solution). The lag phase associated with hydroxypropylcellulose (HPC) as a pore former was not observed when MS was used as a pore former. The drug release from EC/MS-coated pellets was pH independent, inversely proportional to the coating levels, and directly related to the pore former levels. The functional coating layer with MS as a pore former was not completely stabilized without curing. Curing at 60°C for 1 day could substantially improve the stability of EC/MS-coated pellets. The physical state of the drug in the free film of EC/MS (85:15) changed partially from amorphous to crystal when cured at 60°C for 1 day, which should be attributed to the incompatibility of the drug with EC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25163432      PMCID: PMC4309812          DOI: 10.1208/s12249-014-0197-5

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  36 in total

1.  Studies on modifying the tackiness and drug release of Kollicoat EMM 30 D coatings.

Authors:  H Erdmann; S Gebert; K Kolter; G Schepky
Journal:  Drug Dev Ind Pharm       Date:  2003-04       Impact factor: 3.225

2.  Constant potassium chloride release from microporous membrane-coated tablets prepared with aqueous colloidal polymer dispersions.

Authors:  R Bodmeier; O Paeratakul
Journal:  Pharm Res       Date:  1991-03       Impact factor: 4.200

3.  The effect of pore formers on the controlled release of cefadroxil from a polyurethane matrix.

Authors:  J E Kim; S R Kim; S H Lee; C H Lee; D D Kim
Journal:  Int J Pharm       Date:  2000-05-15       Impact factor: 5.875

4.  Anti-tack action of polyvinylpyrrolidone on hydroxypropylmethylcellulose solution.

Authors:  Lai Wah Chan; Tin Wui Wong; Pih Chng Chua; Peter York; Paul Wan Sia Heng
Journal:  Chem Pharm Bull (Tokyo)       Date:  2003-02       Impact factor: 1.645

5.  Effect of the manufacturing conditions on the structure and permeability of polymer films intended for coating undergoing phase separation.

Authors:  Mariagrazia Marucci; Johan Arnehed; Annica Jarke; Hanna Matic; Mark Nicholas; Catherine Boissier; Christian von Corswant
Journal:  Eur J Pharm Biopharm       Date:  2012-10-12       Impact factor: 5.571

6.  pH-independent release of a basic drug from pellets coated with the extended release polymer dispersion Kollicoat SR 30 D and the enteric polymer dispersion Kollicoat MAE 30 DP.

Authors:  A Dashevsky; K Kolter; R Bodmeier
Journal:  Eur J Pharm Biopharm       Date:  2004-07       Impact factor: 5.571

7.  Influences of layering on theophylline pellet characteristics.

Authors:  Nuttanan Sinchaipanid; Padungkwan Chitropas; Ampol Mitrevej
Journal:  Pharm Dev Technol       Date:  2004       Impact factor: 3.133

Review 8.  Controlled release metoprolol. Clinical pharmacokinetic and therapeutic implications.

Authors:  M J Kendall; S R Maxwell; A Sandberg; G Westergren
Journal:  Clin Pharmacokinet       Date:  1991-11       Impact factor: 6.447

9.  Development and evaluation of osmotically controlled oral drug delivery system of glipizide.

Authors:  Rajan K Verma; Sanjay Garg
Journal:  Eur J Pharm Biopharm       Date:  2004-05       Impact factor: 5.571

10.  Development and evaluation of extended release formulations of isosorbide mononitrate based on osmotic technology.

Authors:  Rajan K Verma; Aditya M Kaushal; Sanjay Garg
Journal:  Int J Pharm       Date:  2003-09-16       Impact factor: 5.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.